Cross-linking is a minimally invasive, FDA approved, outpatient procedure that combines the use of prescription eye drops (Riboflavin) and ultra-violet A (UVA) light from the CXL device for the treatment of progressive keratoconus or post-LASIK ectasia. This treatment stabilizes the cornea to prevent further progression.
